InvestorsHub Logo

livendi

12/08/19 5:22 PM

#16227 RE: ernie44 #16226

All that Matters is we have EU approval already in hand three different PEdi trails going on and macrilen many uses coming to fruition And also Novo finally taking over North American sales and only 20 mill shares outstanding. This will be 5 to 10 a share within a yr